Loading...
Market
What will be the outcome of Abbott Laboratories' appeal against the $495 million verdict by December 31, 2024?
2
Resolution / Starting Odds
Verdict upheld • 25%
Verdict overturned • 25%
Settlement reached • 25%
Other • 25%
Court records, official press releases from Abbott Laboratories
Story
Missouri Jury Orders Abbott to Pay $495 Million in Infant Formula Case
Jul 27, 2024, 12:32 AM
Abbott Laboratories has been ordered to pay $495 million in damages after a Missouri jury found that its specialized formula for premature infants caused a serious gastrointestinal disease in an Illinois girl. The jury determined that Abbott failed to warn about the increased risk of developing the potentially fatal bowel disease. The verdict was reached on Friday, with the jury awarding compensatory damages to the affected family. The case has led to a significant financial impact on Abbott, as reflected in the company's stock performance.
View original story
Similar markets
Yes • 50%
No • 50%
Less than $495 million • 25%
$495 million • 25%
More than $495 million but less than $600 million • 25%
More than $600 million • 25%
Verdict upheld • 25%
Verdict overturned • 25%
Settlement reached • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Verdict Upheld • 25%
Verdict Overturned • 25%
Sentence Reduced • 25%
New Trial Ordered • 25%
Verdict upheld • 25%
Verdict overturned • 25%
Verdict modified • 25%
Appeal withdrawn • 25%
Approved without modifications • 25%
Approved with modifications • 25%
Rejected • 25%
Other • 25%